Alto Neuroscience, Inc.
ANRO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,431 | -$36,305 | -$27,710 | -$9,187 |
| Dep. & Amort. | $502 | $373 | $342 | $145 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,631 | $2,891 | $1,763 | $227 |
| Change in WC | $4,060 | -$698 | $4,579 | -$572 |
| Other Non-Cash | $1,814 | $291 | $632 | $125 |
| Operating Cash Flow | -$47,424 | -$33,448 | -$20,394 | -$9,262 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,075 | -$470 | -$732 | -$680 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,075 | -$470 | -$732 | -$680 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,250 | $0 | $9,825 | $0 |
| Stock Issued | $137,579 | $0 | $43 | $7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,138 | $68,130 | $33,921 | $31,681 |
| Financing Cash Flow | $135,691 | $68,130 | $43,789 | $31,688 |
| Forex Effect | -$11 | -$8 | -$24 | -$50 |
| Net Chg. in Cash | $86,181 | $34,204 | $22,639 | $21,696 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82,548 | $48,344 | $25,705 | $4,009 |
| End Cash | $168,729 | $82,548 | $48,344 | $25,705 |
| Free Cash Flow | -$49,499 | -$33,918 | -$21,126 | -$9,942 |